Genpact (NYSE:G – Free Report) had its target price lifted by Mizuho from $45.00 to $55.00 in a report released on Monday morning,Benzinga reports. They currently have a neutral rating on the business services provider’s stock.
A number of other analysts also recently commented on G. Jefferies Financial Group upgraded Genpact from a “hold” rating to a “buy” rating and upped their target price for the stock from $44.00 to $55.00 in a research note on Tuesday, January 21st. TD Cowen upgraded Genpact from a “hold” rating to a “buy” rating and upped their price objective for the stock from $45.00 to $60.00 in a research report on Friday. Needham & Company LLC raised their price objective on shares of Genpact from $55.00 to $65.00 and gave the stock a “buy” rating in a research note on Friday. Finally, Robert W. Baird boosted their target price on shares of Genpact from $44.00 to $48.00 and gave the company a “neutral” rating in a research note on Friday, November 8th. Six research analysts have rated the stock with a hold rating and four have issued a buy rating to the company. According to MarketBeat, the stock currently has an average rating of “Hold” and a consensus target price of $48.44.
Read Our Latest Research Report on G
Genpact Stock Down 1.1 %
Genpact (NYSE:G – Get Free Report) last released its earnings results on Thursday, February 6th. The business services provider reported $0.82 EPS for the quarter, missing analysts’ consensus estimates of $0.86 by ($0.04). Genpact had a return on equity of 22.61% and a net margin of 10.77%. Equities research analysts forecast that Genpact will post 3.08 EPS for the current fiscal year.
Genpact Increases Dividend
The firm also recently announced a quarterly dividend, which will be paid on Wednesday, March 26th. Shareholders of record on Tuesday, March 11th will be given a $0.17 dividend. The ex-dividend date is Tuesday, March 11th. This represents a $0.68 dividend on an annualized basis and a yield of 1.25%. This is an increase from Genpact’s previous quarterly dividend of $0.15. Genpact’s payout ratio is currently 23.94%.
Insider Buying and Selling
In related news, SVP Piyush Mehta sold 12,000 shares of the firm’s stock in a transaction dated Friday, January 10th. The stock was sold at an average price of $42.83, for a total transaction of $513,960.00. Following the completion of the transaction, the senior vice president now directly owns 151,182 shares in the company, valued at $6,475,125.06. This trade represents a 7.35 % decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available through this link. Also, CEO Balkrishan Kalra sold 9,000 shares of the business’s stock in a transaction dated Monday, November 25th. The stock was sold at an average price of $46.40, for a total transaction of $417,600.00. Following the sale, the chief executive officer now owns 267,404 shares in the company, valued at $12,407,545.60. This trade represents a 3.26 % decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last ninety days, insiders sold 35,058 shares of company stock valued at $1,558,675. 2.80% of the stock is currently owned by insiders.
Institutional Investors Weigh In On Genpact
Several large investors have recently bought and sold shares of G. Victory Capital Management Inc. lifted its stake in Genpact by 18.1% during the fourth quarter. Victory Capital Management Inc. now owns 9,853,437 shares of the business services provider’s stock worth $423,205,000 after purchasing an additional 1,511,790 shares during the last quarter. Franklin Resources Inc. raised its stake in shares of Genpact by 6.5% during the third quarter. Franklin Resources Inc. now owns 4,148,185 shares of the business services provider’s stock worth $162,318,000 after purchasing an additional 252,674 shares during the last quarter. Geode Capital Management LLC increased its stake in Genpact by 12.6% in the 3rd quarter. Geode Capital Management LLC now owns 3,691,406 shares of the business services provider’s stock valued at $148,142,000 after buying an additional 413,646 shares during the period. JPMorgan Chase & Co. lifted its position in Genpact by 192.8% in the third quarter. JPMorgan Chase & Co. now owns 3,129,341 shares of the business services provider’s stock valued at $122,701,000 after purchasing an additional 2,060,595 shares during the period. Finally, Tandem Investment Advisors Inc. increased its position in Genpact by 390.5% during the 4th quarter. Tandem Investment Advisors Inc. now owns 2,129,915 shares of the business services provider’s stock worth $91,480,000 after purchasing an additional 1,695,706 shares during the period. Hedge funds and other institutional investors own 96.03% of the company’s stock.
About Genpact
Genpact Limited provides business process outsourcing and information technology services in India, rest of Asia, North and Latin America, and Europe. It operates through three segments: Financial services; Consumer and Healthcare; and High Tech and Manufacturing. The Financial Services segment offers retail customer onboarding, customer service, collections, card servicing operations, loan and payment operations, commercial loan, equipment and auto loan, mortgage origination, compliance services, reporting and monitoring, and wealth management operations support; financial crime and risk management services; and underwriting support, new business processing, policy administration, claims management, catastrophe modeling and actuarial services, as well as property and casualty claims.
Recommended Stories
- Five stocks we like better than Genpact
- 3 Grocery Stocks That Can Help Take a Bite Out of Inflation
- Merck: 4 No-Brainer Reasons to Buy This Dip
- What is the Dogs of the Dow Strategy? Overview and Examples
- Ackman Announces Major Stake in Uber: Should You Follow His Lead?
- What Do S&P 500 Stocks Tell Investors About the Market?
- Wells Fargo Upgraded These 3 Stocks—Here’s Why They Stand Out
Receive News & Ratings for Genpact Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Genpact and related companies with MarketBeat.com's FREE daily email newsletter.